Dr. Solomon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5670 Peachtree Dunwoody Rd
Ste 1000
Atlanta, GA 30342Phone+1 404-255-1930Fax+1 404-459-8510
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1998 - 2001
- University of California (San Francisco)Residency, Internal Medicine, 1995 - 1998
- University of Maryland School of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 1997 - Present
- GA State Medical License 2005 - 2025
- MD State Medical License 2000 - 2005
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Start of enrollment: 2004 Aug 01
- Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer Start of enrollment: 2008 Oct 01
- Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer Start of enrollment: 2005 May 01
- Join now to see all
Publications & Presentations
PubMed
- 271 citationsCTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantationAsad Bashey, Bridget Medina, Sue Corringham, Mildred Pasek, Ewa Carrier
Blood. 2009-02-12 - 3 citationsExtracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD).Melhem M Solh, Chloe Farnham, Scott R Solomon, Asad Bashey, Lawrence E Morris
Bone Marrow Transplantation. 2023-02-01 - 1184 citationsLisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study.Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon, Matthew A. Lunning, Michael Wang
Lancet. 2020-09-19
Abstracts/Posters
- Graft Versus Host Disease (GVHD) after HLA-Mismatched Haploidentical Transplantation with Post-Transplant Cyclophosphamide Compared to Matched Unrelated Donor: Inciden...Scott R. Solomon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- SEL120 _ a First-in-Class CDK8/19 Inhibitor As a Novel Option for the Treatment of Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome - Data from Preclinica...Scott R. Solomon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Improved Survival in Patients Who Undergo Relapse of Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell TransplantationScott R. Solomon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Ixazomib Maintenance to Prevent Alloreactivity and Provide Anti-Malignancy Effects Following Nonmyeloablative T-Replete Haploidentical Peripheral Blood Stem Cell Trans...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- First in Human Study of SEL24/MEN1703, First in Class, Orally Available Dual PIM/FLT3 Kinase Inhibitor, in Patients with Acute Myeloid Leukemia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: